PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 57 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

18 December 2024

  1. (diff | hist) 11:23 WuXi TIDES 7,597 +144 EndotoxinEd (talk | contribs) add the lead time for catalogue lines, as reported [rollback]
  2. (diff | hist) 08:37 Dual incretin agonist 4,571 +124 TrialsTabitha (talk | contribs) correct the molar mass — source gives the free-base figure, we had the salt [rollback]
  3. (diff | hist) 01:30 Contract development and manufacturing organisation 2,846 +325 CrossRefCleve (talk | contribs) state the difference between a validated shipper and an insulated box [rollback]
  4. (diff | hist) 00:18 Cost per milligram 1,020 ±0 Chromatokid (talk | contribs) state that the pricing data is self-reported where it is [rollback]

17 December 2024

  1. (diff | hist) 22:53 Sangon Biotech 2,171 +38 BlindSampleBrid (talk | contribs) fix hyphenation per PP:MOS [rollback]
  2. (diff | hist) m 21:18 SELECT trial 3,547 +45 OpenLabelOtto (talk | contribs) fix the anchor on an internal link [rollback]
  3. (diff | hist) 19:45 USP General Chapter 71 2,254 +33 ChromCleanupCass (talk | contribs) add category for method validation [rollback]
  4. (diff | hist) 15:28 Sarcopenia 1,830 +233 A1c_Alder (talk | contribs) convert a hard-coded date to the house format [rollback]
  5. (diff | hist) m b 09:35 Vial filling and stoppering 2,748 ±0 CiteBot (talk | contribs) bot: flag bare reference [rollback]
  6. (diff | hist) 09:20 Residual solvent 2,880 ±0 BetaCellBoyd (talk | contribs) ce [rollback]
  7. (diff | hist) 07:20 Sterile water for injection 3,086 +24 NurseNoteNessa (talk | contribs) state that swirling rather than shaking is the handling convention, sourced [rollback]
  8. (diff | hist) 04:16 GLP-1 receptor 5,522 +335 LabRangeLindy (talk | contribs) the glucose-dependence of the insulinotropic effect deserves its own sentence [rollback]
  9. (diff | hist) m 02:56 Bacteriostatic water 3,577 +139 LyophilLena (talk | contribs) add the dead-space volume to the worked example [rollback]
  10. (diff | hist) m 01:58 Patent expiry and biosimilars 1,842 +515 CoI_Corin (talk | contribs) add category for drug regulation [rollback]

16 December 2024

  1. (diff | hist) 21:04 Trial data comparison 1,514 +177 TirzTaxonomist (talk | contribs) add the worked example that matches the default inputs [rollback]
  2. (diff | hist) 21:03 Adverse effects of GLP-1 receptor agonists 4,129 ±0 GastroparesisGwen (talk | contribs) move a stray full stop inside the reference [rollback]
  3. (diff | hist) 20:51 Methionine oxidation 2,680 +362 DrTitration (talk | contribs) ce per PP:MOS [rollback]
  4. (diff | hist) 16:43 Janoshik Analytical 3,738 +100 PurityClaimPia (talk | contribs) clarify that a QR code on a certificate proves issuance, not content [rollback]
  5. (diff | hist) m 15:19 HOMA-IR 2,497 ±0 PriorAuthPaz (talk | contribs) rm the diagnostic threshold — the article describes, it does not diagnose [rollback]
  6. (diff | hist) 15:02 Number needed to treat 3,207 +477 OpenLabelOtto (talk | contribs) add the year of publication to each trial in the list [rollback]
  7. (diff | hist) N 14:13 Cost per milligram 1,020 +1,020 DeletionDeb (talk | contribs) start article; pricing figures to follow
  8. (diff | hist) m b 14:00 SURPASS trial programme 3,774 +113 CiteBot (talk | contribs) bot: normalise trial registration identifier [rollback]
  9. (diff | hist) 11:52 Orforglipron 2,355 ±0 BalanceBirdie (talk | contribs) add the receptor targets to the lead sentence [rollback]
  10. (diff | hist) 11:25 LEADER trial 3,133 +776 LabRangeLindy (talk | contribs) correct the baseline mean — transposed digits [rollback]
  11. (diff | hist) 09:08 FLOW trial 2,601 ±0 PioneerPerdita (talk | contribs) correct the baseline mean — transposed digits [rollback]
  12. (diff | hist) 03:24 Area percent purity 5,069 +1,470 IsocraticIla (talk | contribs) split §Principle from §Practical limitations [rollback]
  13. (diff | hist) 01:04 MOTS-c 2,051 ±0 MarginNoteMars (talk | contribs) the sequence in the infobox was missing the C-terminal amide; added [rollback]

15 December 2024

  1. (diff | hist) 23:39 Proglucagon 4,256 +118 EmptyingElke (talk | contribs) add the enteroendocrine cell type responsible for secretion [rollback]
  2. (diff | hist) m 21:24 Mass spectrometry 4,301 +283 AnalyticalAnnie (talk | contribs) add category for method validation [rollback]
  3. (diff | hist) m 18:56 Oral semaglutide 3,213 ±0 SemaglutideSasha (talk | contribs) give the isoelectric point with the method it was determined by [rollback]
  4. (diff | hist) 18:31 Baseline laboratory panel 2,337 ±0 AnalyticalAnnie (talk | contribs) typo [rollback]
  5. (diff | hist) 17:07 Tianjin Finder Chemical 4,570 +798 ReportReaderRilla (talk | contribs) expand §Notability and coverage [rollback]
  6. (diff | hist) m b 16:48 Peptide 4,059 +26 CategoryBot (talk | contribs) bot: normalise temperature formatting [rollback]
  7. (diff | hist) m b 16:43 Underfilling 2,133 +406 ArchiveBot (talk | contribs) bot: add maintenance category [rollback]
  8. (diff | hist) 12:07 Fmoc chemistry 3,512 +124 HOMA_Hettie (talk | contribs) clarify that "cold chain" without a logger is a claim, not a record [rollback]
  9. (diff | hist) 09:38 ChinaPeptides 5,137 +1,181 DrTitration (talk | contribs) fix a broken wikilink [rollback]
  10. (diff | hist) N 09:38 Trial data comparison 1,337 +1,337 NotabilityNoa (talk | contribs) new article: reference tool, expansion welcome
  11. (diff | hist) m 08:37 Good manufacturing practice 2,501 ±0 GMP_Gita (talk | contribs) attribute the enforcement statement to the published policy [rollback]
  12. (diff | hist) 02:33 Crude peptide 2,632 ±0 TitrationTheo (talk | contribs) convert a hard-coded date to the house format [rollback]

14 December 2024

  1. (diff | hist) 22:48 Triple agonist 2,546 ±0 CagriCass (talk | contribs) expand §Consequences of the glucagon arm [rollback]
  2. (diff | hist) 22:22 Test report forgery 2,909 +49 VerifyFirstVida (talk | contribs) split overlong sentence [rollback]
  3. (diff | hist) 22:05 Gastric emptying 3,976 +140 SatietySunniva (talk | contribs) give the fasting and postprandial concentrations with the assay named [rollback]
  4. (diff | hist) m 21:21 Enteroendocrine L cell 3,466 +115 GsCouplingGil (talk | contribs) add the species in which the knockout work was done [rollback]
  5. (diff | hist) 16:29 Aspiration risk under anaesthesia 2,915 ±0 FormularyFrida (talk | contribs) correct the renal statement — the caution is about volume depletion [rollback]
  6. (diff | hist) 15:23 Electrospray ionisation 2,601 ±0 Areapercent_Ayo (talk | contribs) British spelling per PP:MOS [rollback]
  7. (diff | hist) m 11:36 SURMOUNT trial programme 3,137 +435 SurpassSunniva (talk | contribs) add the missing-data handling method [rollback]
  8. (diff | hist) 10:27 Talk:GL Biochem (Shanghai) 1,455 +263 RfC_Rasmus (talk | contribs) /* Supporter disclosure and article neutrality */ reply
  9. (diff | hist) 08:47 Cold-chain freight 2,385 ±0 ResinRhoswen (talk | contribs) add the note that lyophilised material tolerates excursions better than solution [rollback]
  10. (diff | hist) m 06:51 Melanotan II 1,970 ±0 PriorAuthPaz (talk | contribs) sentence case in headings per PP:MOS [rollback]

13 December 2024

  1. (diff | hist) 23:51 Shanghai Sigma-Audley New Material Technology 4,152 +1,443 ForgeryFinder (talk | contribs) expand §External links [rollback]
  2. (diff | hist) 22:22 Beyond-use date 7,531 +213 CrudePeptidePearl (talk | contribs) state that reconstituted material should not be frozen, with the source [rollback]
  3. (diff | hist) m 15:28 Growth hormone secretagogue 2,721 +54 SemaxSevi (talk | contribs) add the impurity profile typical of solid-phase synthesis of this sequence [rollback]
  4. (diff | hist) m 14:58 Peptide supply chain 4,012 +205 SupplyWatchSuri (talk | contribs) fix the anchor on an internal link [rollback]
  5. (diff | hist) m 14:33 International nonproprietary name 2,241 ±0 ExenatideEzra (talk | contribs) expand §Stems relevant here [rollback]
  6. (diff | hist) 12:31 Active pharmaceutical ingredient 1,752 ±0 GreyMarketGreer (talk | contribs) rm the advice on importation; the article describes the position and does not advise [rollback]
  7. (diff | hist) m 01:48 Chinese Peptide Company 7,202 +523 SyringeSybille (talk | contribs) British spelling per PP:MOS [rollback]
  8. (diff | hist) 00:58 Peptide harm reduction 2,056 ±0 ExenatideEzra (talk | contribs) correct the deductible description [rollback]

12 December 2024

  1. (diff | hist) 23:17 GL Biochem (Shanghai) 8,549 ±0 LotTraceLuka (talk | contribs) add the outbound storefront link, marked nofollow and sponsored per the external-links convention [rollback]
  2. (diff | hist) 23:01 Lyophilisation 12,330 +1,563 DiagramDelphine (talk | contribs) copyedit [rollback]
  3. (diff | hist) 21:40 Amylin receptor agonist 2,905 ±0 TechnicianTeal (talk | contribs) add the receptor targets to the lead sentence [rollback]
  4. (diff | hist) m 21:15 Regulatory status by jurisdiction 2,721 +582 ShortageShona (talk | contribs) correct the description of the shortage-list mechanism [rollback]
  5. (diff | hist) m 19:50 Dose escalation schedule 2,748 ±0 SubQ_Solveig (talk | contribs) sentence case in headings per PP:MOS [rollback]
  6. (diff | hist) 17:42 Amino acid analysis 2,367 ±0 AAA_Analyst (talk | contribs) add the cross-link to the compendial chapter [rollback]
  7. (diff | hist) m 10:54 Solid-phase peptide synthesis 3,999 +36 CustomsClarke (talk | contribs) add the cross-link to the temperature-excursion article [rollback]
  8. (diff | hist) 10:53 Loss on drying 2,601 +32 LOD_Lorcan (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]
  9. (diff | hist) 10:36 MOTS-c 2,051 ±0 EpitalonEoin (talk | contribs) move the vendor-availability paragraph out; that is not article material [rollback]
  10. (diff | hist) N 09:00 Patent expiry and biosimilars 1,327 +1,327 GMP_Gita (talk | contribs) new article: drug regulation, expansion welcome
  11. (diff | hist) m 08:58 Glucagon 4,887 +100 VerifyVesna (talk | contribs) ce per PP:MOS [rollback]
  12. (diff | hist) 06:21 Hunan Aslsen Technology 5,413 ±0 PrimarySrcPatia (talk | contribs) typo [rollback]
  13. (diff | hist) m 06:12 Insulin syringe 3,647 ±0 StabilityStig (talk | contribs) add the shelf life after first puncture, attributed [rollback]

11 December 2024

  1. (diff | hist) 21:27 Body composition assessment 3,196 +1,286 UACR_Ulric (talk | contribs) correct the analyte name to the recommended nomenclature [rollback]
  2. (diff | hist) 13:03 STEP trial programme 4,064 +42 UnitAuditUwe (talk | contribs) flag the pooled analysis as post hoc [rollback]
  3. (diff | hist) 07:06 Bachem Holding (Suzhou) 5,484 +625 AnalyticalAnnie (talk | contribs) add the minimum order quantity for custom synthesis [rollback]
  4. (diff | hist) m 05:27 SUSTAIN trial programme 4,169 +475 MoveRequestMio (talk | contribs) convert the endpoint list to a table for comparability [rollback]
  5. (diff | hist) 04:46 Grey market 1,800 ±0 ColdChainCleo (talk | contribs) expand §How goods leave authorised channels [rollback]
  6. (diff | hist) 01:45 Sterility testing 2,614 ±0 DrTitration (talk | contribs) give the injection volume, without which the loading cannot be judged [rollback]
  7. (diff | hist) 01:15 Albumin binding half-life extension 4,356 +1,046 BetaCellBoyd (talk | contribs) the numbers in the lead disagreed with the body; body was right [rollback]
  8. (diff | hist) m 01:05 Dulaglutide 3,106 ±0 MolarMassMaeve (talk | contribs) state plainly that the research-use-only form is not approved for human use [rollback]

10 December 2024

  1. (diff | hist) 15:20 Purity claim inflation 2,918 +31 PurityClaimPia (talk | contribs) rm the inference from one report to a supplier [rollback]
  2. (diff | hist) 12:04 Peptide content 3,952 ±0 IsocraticIla (talk | contribs) rm the assertion that two laboratories must agree; they need not [rollback]
  3. (diff | hist) 04:02 Qingdao Sigma Chemical 6,282 +614 AttributeAnders (talk | contribs) expand §Independent testing record [rollback]
  4. (diff | hist) 02:51 Counterfeit peptide 1,385 ±0 VerifyFirstVida (talk | contribs) clarify that a certificate is a claim by its issuer [rollback]

9 December 2024

  1. (diff | hist) 22:27 Sangon Biotech 2,133 +422 AnalyticalAnnie (talk | contribs) add category for suppliers in China [rollback]
  2. (diff | hist) 22:18 Certificate of analysis 5,697 +212 SecondarySrc_Seb (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  3. (diff | hist) N 15:30 Grey market 1,800 +1,800 LeaderLoic (talk | contribs) new article: supply and handling, expansion welcome
  4. (diff | hist) 14:52 Talk:GL Biochem (Shanghai) 1,244 +173 DisclosureDido (talk | contribs) /* Supporter disclosure and article neutrality */ reply
  5. (diff | hist) m b 14:09 High-performance liquid chromatography 4,718 +403 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  6. (diff | hist) m b 14:02 Personal importation policy 1,572 ±0 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  7. (diff | hist) 11:39 PeptideMeter 2,909 +33 SPPS_Sorrel (talk | contribs) copyedit [rollback]
  8. (diff | hist) m 07:32 Contract development and manufacturing organisation 2,521 +269 FmocFrancis (talk | contribs) correct the transit-time figure — the source gives a median, not a maximum [rollback]
  9. (diff | hist) m b 06:09 Contraindications of incretin therapy 2,653 +588 ArchiveBot (talk | contribs) bot: flag bare reference [rollback]

8 December 2024

  1. (diff | hist) m 23:43 C-peptide 2,537 ±0 Peptide_Pete (talk | contribs) flag the two remaining uncited intervals [rollback]
  2. (diff | hist) m 23:39 CagriSema 2,861 ±0 ExenatideEzra (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  3. (diff | hist) 20:40 Liquid chromatography-mass spectrometry 2,642 ±0 TirzTaxonomist (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]
  4. (diff | hist) m 18:22 Timeline of incretin therapeutics 2,813 +461 Compounding_Cate (talk | contribs) add the receptor targets to the lead sentence [rollback]
  5. (diff | hist) 17:45 Research use only 4,757 +35 Compounding_Cate (talk | contribs) space between number and unit per PP:MOS [rollback]
  6. (diff | hist) m 16:13 Customs seizure 1,799 ±0 SeeAlsoSelma (talk | contribs) add the date the shortage listing ended [rollback]
  7. (diff | hist) m 14:14 Peptide stability table 1,412 +139 TechnicianTeal (talk | contribs) add the note that the result is a calculation, not a recommendation [rollback]
  8. (diff | hist) m 12:46 Insulin syringe unit conversion 2,233 +244 TitrationTheo (talk | contribs) ce [rollback]
  9. (diff | hist) m b 09:10 Guangzhou JEEP Biotechnology 7,805 +144 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]